8 Einträge gefunden

1. Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.

   1. Fleischmann, A
   2. Huland, Hartwig
   3. Mirlacher, Martina
   4. Wilczak, Waldemar
   5. Simon, Ronald
   6. Erbersdobler, Andreas
   7. Sauter, G

   2012 - Forschungsinformationssystem des UKE
2. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

   1. Tennstedt, Pierre
   2. Köster, Patricia
   3. Brüchmann, Andreas
   4. Mirlacher, Martina
   5. Haese, Alexander
   6. Steuber, Thomas
   7. Sauter, Guido

   2012 - Forschungsinformationssystem des UKE
3. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.

   1. Erbersdobler, Andreas
   2. Isbarn, Hendrik
   3. Steiner, Isabel
   4. Schlomm, Thorsten
   5. Chun, Felix
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
4. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

   1. Erbersdobler, Andreas
   2. Isbarn, Hendrik
   3. Dix, Kira
   4. Steiner, Isabel
   5. Schlomm, Thorsten
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
5. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Köllermann, Jens
   4. Sekulic, Nikolina
   5. Huland, Hartwig
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
6. Clinical significance of p53 alterations in surgically treated prostate cancers.

   1. Schlomm, Thorsten
   2. Iwers, Liv
   3. Kirstein, Patrick
   4. Jessen, Birte
   5. Köllermann, Jens
   6. Minner, Sarah
   7. Passow-Drolet, Annika

   2008 - Forschungsinformationssystem des UKE
7. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Huland, Hartwig
   4. Köllermann, Jens
   5. Simon, Philipp
   6. Mirlacher, Martina
   7. Salomon, Georg

   2008 - Forschungsinformationssystem des UKE
8. Molecular staging of prostate cancer in the year 2007.

   1. Schlomm, Thorsten
   2. Erbersdobler, Andreas
   3. Mirlacher, Martina
   4. Sauter, Guido

   2007 - Forschungsinformationssystem des UKE